|
ATP2B1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.46149999949941E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.35299999999938E-05 |
| Normal-vs-Stage2 |
2.19119999999018E-05 |
| Normal-vs-Stage3 |
1.65569999999171E-06 |
| Normal-vs-Stage4 |
9.982700E-03 |
| Stage1-vs-Stage2 |
2.034000E-01 |
| Stage1-vs-Stage3 |
1.166800E-01 |
| Stage1-vs-Stage4 |
8.669000E-01 |
| Stage2-vs-Stage3 |
9.774800E-01 |
| Stage2-vs-Stage4 |
2.835800E-01 |
| Stage3-vs-Stage4 |
2.614200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.15290000055357E-07 |
| Normal-vs-AfricanAmerican |
2.767900E-02 |
| Normal-vs-Asian |
5.264600E-01 |
| Caucasian-vs-AfricanAmerican |
5.424200E-01 |
| Caucasian-vs-Asian |
3.424000E-01 |
| AfricanAmerican-vs-Asian |
6.204400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.41589999999681E-05 |
| Normal-vs-Female |
1.60160000040044E-07 |
| Male-vs-Female |
1.125640E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.577700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.71949999999899E-05 |
| Normal-vs-Age(61-80Yrs) |
4.4031999999472E-06 |
| Normal-vs-Age(81-100Yrs) |
3.20080000282275E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.101400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.133000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.321200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.835400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.198110E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.241000E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.882300E-02 |
| Normal-vs-Grade 2 |
3.360900E-04 |
| Normal-vs-Grade 3 |
2.50509946120303E-10 |
| Normal-vs-Grade 4 |
1.529550E-02 |
| Grade 1-vs-Grade 2 |
7.980800E-01 |
| Grade 1-vs-Grade 3 |
4.241000E-01 |
| Grade 1-vs-Grade 4 |
8.498200E-01 |
| Grade 2-vs-Grade 3 |
2.788000E-02 |
| Grade 2-vs-Grade 4 |
9.784600E-01 |
| Grade 3-vs-Grade 4 |
2.252600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.01899624691282E-11 |
| Normal-vs-ccB subtype |
7.065500E-02 |
| ccA subtype-vs-ccB subtype |
1.006040E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.01230000004726E-06 |
| Normal-vs-N1 |
3.464800E-01 |
| N0-vs-N1 |
2.094800E-01 |
|
|
